CINECA IRIS Institutional Research Information System

BELLOMO, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.022
NA - Nord America 453
SA - Sud America 336
EU - Europa 268
Continente sconosciuto - Info sul continente non disponibili 58
AF - Africa 20
Totale 2.157
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 400
BR - Brasile 276
HK - Hong Kong 228
SG - Singapore 216
BD - Bangladesh 178
IT - Italia 167
VN - Vietnam 166
CN - Cina 137
DE - Germania 54
KR - Corea 32
CA - Canada 22
ID - Indonesia 22
AR - Argentina 19
MX - Messico 19
FR - Francia 18
IN - India 16
EC - Ecuador 14
CO - Colombia 8
CL - Cile 6
PH - Filippine 5
UA - Ucraina 5
KE - Kenya 4
PE - Perù 4
PL - Polonia 4
RU - Federazione Russa 4
ZA - Sudafrica 4
AZ - Azerbaigian 3
GB - Regno Unito 3
HN - Honduras 3
JM - Giamaica 3
MA - Marocco 3
NL - Olanda 3
UY - Uruguay 3
VE - Venezuela 3
BE - Belgio 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
ES - Italia 2
ET - Etiopia 2
GT - Guatemala 2
IL - Israele 2
IQ - Iraq 2
OM - Oman 2
PK - Pakistan 2
PY - Paraguay 2
SE - Svezia 2
TN - Tunisia 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
GE - Georgia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PT - Portogallo 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.100
Salva come PNG Salva come JPEG
Città #
Hong Kong 228
Ho Chi Minh City 61
Ashburn 54
Frankfurt am Main 52
San Jose 40
Beijing 38
Hanoi 34
Singapore 34
Seoul 32
New York 30
Rome 21
Council Bluffs 19
Chicago 18
Los Angeles 18
Santa Clara 17
Milan 16
São Paulo 16
Princeton 14
Buffalo 12
Naples 12
Dallas 10
Haiphong 9
Mexico City 9
Abbeville 8
Brasília 8
Guayaquil 7
Rio de Janeiro 7
Toronto 7
Palermo 6
Porto Alegre 6
Salvador 6
Campinas 5
Da Nang 5
Thái Bình 5
Belo Horizonte 4
Chennai 4
Duque de Caxias 4
Florence 4
Genoa 4
Jundiaí 4
Las Vegas 4
Manaus 4
Miami 4
Nairobi 4
Ninh Bình 4
Phoenix 4
Ribeirão Preto 4
Thái Nguyên 4
Venice 4
Bauru 3
Bengaluru 3
Bogotá 3
Bắc Ninh 3
Can Tho 3
Cincinnati 3
Curitiba 3
Hải Dương 3
Jakarta 3
Lima 3
Mauá 3
Orem 3
Pasadena 3
Piracicaba 3
Portland 3
Queens 3
Quito 3
Reston 3
Santo André 3
Seattle 3
Uberlândia 3
Varginha 3
Verona 3
Addis Ababa 2
Alvorada 2
Americana 2
Aracaju 2
Arlington 2
Baku 2
Belém 2
Biên Hòa 2
Bologna 2
Brooklyn 2
Buenos Aires 2
Cabo Frio 2
Cagliari 2
Calgary 2
Cariacica 2
Catania 2
Colombo 2
Esmeraldas 2
Formosa 2
Fortaleza 2
Goiânia 2
Guarulhos 2
Hillsboro 2
Hưng Yên 2
Indaiatuba 2
Indpls 2
Itaquaquecetuba 2
Jacksonville 2
Totale 1.049
Salva come PNG Salva come JPEG
Nome #
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum 208
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: Disease staging by NF-L, p-tau181, and GFAP 90
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 85
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 80
Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson’s Disease 68
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction 60
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders 59
Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease 54
Association of αS-SAA kinetics with clinical scores in the clinical spectrum of Parkinson's disease 54
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: Relevance for α-synuclein measurement 53
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment 53
The National Italian Guidelines on the diagnosis and treatment of children with pediatric ataxias 51
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays 50
Diagnostic performance of plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non‐AD dementias: An international multi‐center study 49
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid 48
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward 45
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions 44
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 44
Are we ready for detecting α-synuclein prone to aggregation in patients? The case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as diagnostic tools 44
An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity? 44
Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer’s disease and Parkinson’s disease 41
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 40
Unlocking the full clinical potential of the α-synuclein seed amplification assay 37
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers 36
A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias 36
Serum level changes of the synaptic marker beta-synuclein in Alzheimer’s disease continuum and other dementias 35
MULTIFREQUENCY BIOIMPEDENTIOMETER 32
Revisiting paramagnetic relaxation enhancements in slowly rotating systems: how long is the long range? 32
Aggregation kinetics of the Aβ1-40 peptide monitored by NMR 31
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease 31
Aquaporin-4 as an early cerebrospinal fluid biomarker of Alzheimer’s disease 30
Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids 30
Parkinson's and Lewy body dementia CSF biomarkers 30
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 30
Quantification of SPECT Concentric Ring Artifacts by Radiomics and Radial Features 29
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 29
Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer’s disease biomarkers 29
Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer's Disease 29
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 28
Seed amplification assays for diagnosing synucleinopathies: The issue of influencing factors 28
Modulation of Aβ42 Aggregation Kinetics and Pathway by Low-Molecular-Weight Inhibitors 27
The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis 27
Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias 26
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease 26
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview 24
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics 23
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 22
Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's disease 22
Multivariate Curve Resolution for 2D Solid-State NMR spectra 19
Cellular prion protein and its derived peptides: multifaceted roles in neurodegenerative diseases and potential as biomarkers 8
Phosphorylated α-synuclein in CSF and plasma does not reflect synucleinopathy 5
Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias 2
Totale 2.157
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.538
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.538
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025313 0 0 0 0 1 3 7 4 1 245 42 10
2025/20261.642 88 31 246 344 132 33 34 87 92 125 261 169
2026/2027202 57 40 35 70 0 0 0 0 0 0 0 0
Totale 2.157